Caribou Biosciences provides solutions for cellular engineering and analysis based on the CRISPR-Cas9 technology for gene editing — a technique where DNA is inserted, replaced, or removed from a genome using artificially engineered nucleases. It’s been arguably the hottest advance in biotech, ever — and Caribou has been raising monster venture rounds as it turns this basic scientific advance into practical applications.
Vonnie Estes gave this overview of Caribou at ABLC Next in San Francisco.
